$0.381800
0.025.09%
At Close: -
$0.360200
-0.02-5.66%
After Hours: 7:59 PM EDT
15 minutes delayed
Comments
Loading...
Redhill Biopharma
RDHLNASDAQ
Redhill Biopharma (NASDAQ:RDHL) Stock, Earnings Estimates, EPS, And Revenue
Redhill Biopharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Apr 8
EPS
$0.010
Quarterly Revenue
$6.5M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$6.5M
Analyze the earnings history of Redhill Biopharma using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| RDHL | Redhill Biopharma | $0.09 | — | — | — | $1.80M | — | — | — | 08/15/2024 | Get Alert |
| RDHL | Redhill Biopharma | — | — | — | — | — | — | — | — | 08/15/2024 | Get Alert |
| RDHL | Redhill Biopharma | -$0.12 | — | $0.01 | — | $61.80M | — | $6.53M | — | 04/08/2024 | Get Alert |
| RDHL | Redhill Biopharma | -$0.80 | — | $0.09 | — | $18.35M | — | $1.80M | — | 08/17/2023 | Get Alert |
| RDHL | Redhill Biopharma | $0.04 | — | -$0.05 | — | $13.10M | — | $3.60M | — | 06/12/2023 | Get Alert |
| RDHL | Redhill Biopharma | -$20.00 | — | $0.00 | — | $22.07M | $18.10M | $12.80M | -29.29% | 04/28/2023 | Get Alert |
| RDHL | Redhill Biopharma | -$2.00 | — | -$2.40 | — | $21.61M | $21.24M | $17.55M | — | 11/29/2022 | Get Alert |
| RDHL | Redhill Biopharma | -$2.40 | — | -$0.80 | — | $21.50M | — | $18.35M | — | 11/07/2022 | Get Alert |
| RDHL | Redhill Biopharma | -$2.00 | -$9.20 | -$12.00 | -30.43% | $20.57M | $24.30M | $18.24M | -24.95% | 06/23/2022 | Get Alert |
| RDHL | Redhill Biopharma | -$2.80 | -$13.20 | -$20.00 | -51.52% | $21.46M | $24.08M | $22.07M | -8.34% | 03/17/2022 | Get Alert |
| RDHL | Redhill Biopharma | -$2.00 | -$8.40 | -$20.00 | -138.10% | $20.94M | $24.52M | $21.61M | -11.87% | 11/30/2021 | Get Alert |
| RDHL | Redhill Biopharma | $1.60 | -$4.80 | -$2.40 | 50.00% | $20.90M | $25.02M | $21.50M | -14.06% | 08/26/2021 | Get Alert |
| RDHL | Redhill Biopharma | -$2.00 | -$13.60 | -$2.00 | 85.29% | $1.06M | $22.70M | $20.57M | -9.36% | 05/27/2021 | Get Alert |
| RDHL | Redhill Biopharma | $1.20 | -$9.60 | -$2.80 | 70.83% | $1.59M | $26.03M | $21.46M | -17.55% | 03/18/2021 | Get Alert |
| RDHL | Redhill Biopharma | -$1.20 | -$6.40 | -$2.00 | 68.75% | $1.40M | $25.37M | $20.94M | -17.45% | 11/12/2020 | Get Alert |
| RDHL | Redhill Biopharma | -$1.60 | -$2.80 | -$1.60 | 42.86% | $1.56M | $22.99M | $20.90M | -9.10% | 08/13/2020 | Get Alert |
| RDHL | Redhill Biopharma | -$1.20 | -$9.60 | -$2.00 | 79.17% | $1.74M | $4.38M | $1.06M | -75.89% | 05/27/2020 | Get Alert |
| RDHL | Redhill Biopharma | -$1.20 | -$9.60 | $1.20 | 112.50% | $1.36M | $2.15M | $1.59M | -26.05% | 03/04/2020 | Get Alert |
| RDHL | Redhill Biopharma | -$1.60 | -$15.20 | -$1.20 | 92.11% | $2.21M | $1.77M | $1.40M | -20.85% | 11/19/2019 | Get Alert |
| RDHL | Redhill Biopharma | -$2.00 | -$14.00 | -$1.60 | 88.57% | $2.35M | $2.16M | $1.56M | -27.64% | 07/23/2019 | Get Alert |
Redhill Biopharma (RDHL) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2022 | 2022-06-23 | $-12.00 | $-9.20 | -30.4 % |
| Dec 2021 | 2022-03-17 | $-20.00 | $-13.20 | -51.5 % |
| Sep 2021 | 2021-11-30 | $-20.00 | $-8.40 | -138.1 % |
| Jun 2021 | 2021-08-26 | $-2.40 | $-4.80 | 50.0 % |
Redhill Biopharma (RDHL) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Mar 2023 | 2023-04-28 | $12.80M | $18.10M | -29.3 % |
| Mar 2022 | 2022-06-23 | $18.24M | $24.30M | -24.9 % |
| Dec 2021 | 2022-03-17 | $22.07M | $24.08M | -8.34 % |
| Sep 2021 | 2021-11-30 | $21.61M | $24.52M | -11.9 % |
FAQ
When is Redhill Biopharma (NASDAQ:RDHL) reporting earnings?
Redhill Biopharma (RDHL) is scheduled to report earnings on August 15, 2024. The last reported earnings were for reported on April 8, 2024 for FY.
What were the latest earnings per share (EPS) for Redhill Biopharma (NASDAQ:RDHL)?
The Actual EPS was $0.01, which beat the estimate of $0.00.
What were Redhill Biopharma’s (NASDAQ:RDHL) revenues?
The Actual Revenue was $6.5M, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.